Authors: RAU R SANDER O DENBROEDER A VANRIEL PLCM VANDERPUTTE L KRUGER K SCHATTENKIRCHER M FENNER H LASSMANN A KUPPER H KEMPENI J

Citation: R. Rau et al., LONG-TERM EFFICACY AND TOLERABILITY OF MULTIPLE IV DOSES OF THE FULLYHUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 137-137

Authors: ESSLINGER HU HAAS S MAURER R LASSMANN A DUBBERS K MULLERPELTZER H

Citation: Hu. Esslinger et al., PHARMACODYNAMIC AND SAFETY RESULTS OF PEG-HIRUDIN IN HEALTHY-VOLUNTEERS, Thrombosis and haemostasis, 77(5), 1997, pp. 911-919

Authors: ESSLINGER HU HAAS S LASSMANN A STEMBERGER A BAUMGARTNER M BLUMEL G MULLERPELTZER H

Citation: Hu. Esslinger et al., PHASE-I RESULTS ON PEG-HIRUDIN (LU-57291), A SAFE AND EFFECTIVE ANTICOAGULANT WITH PROLONGED ACTIVITY, Thrombosis and haemostasis, 73(6), 1995, pp. 1452-1452